Standout Papers

The "bystander effect": t... 1993 2026 2004 2015 1993 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.
    1993 915 citations Sara M. Freeman, Camille N. Abboud et al. PubMed profile →

Immediate Impact

4 by Nobel laureates 27 from Science/Nature 56 hit
Sub-graph 1 of 22

Citing Papers

Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 HitNature
Principles and therapeutic applications of adaptive immunity
2024 Hit
2 intermediate papers

Works of F. L. Moolten being referenced

Curability of Tumors Bearing Herpes Thymidine Kinase Genes Transfered by Retroviral Vectors
1990
IMMUNOTHERAPY OF EXPERIMENTAL ANIMAL TUMORS WITH ANTITUMOR ANTIBODIES CONJUGATED TO DIPHTHERIA TOXIN OR RICIN*
1976

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
F. L. Moolten 1.2k 984 474 393 371 16 1.7k
Frederick L. Moolten 946 0.8× 879 0.9× 411 0.9× 407 1.0× 304 0.8× 22 1.7k
Dina Markowitz 1.0k 0.9× 1.3k 1.3× 447 0.9× 161 0.4× 100 0.3× 12 2.0k
Brad E. Hoffman 962 0.8× 953 1.0× 548 1.2× 179 0.5× 139 0.4× 34 1.9k
Kang Hu 530 0.5× 611 0.6× 534 1.1× 128 0.3× 157 0.4× 27 1.3k
Heung Chong 758 0.6× 871 0.9× 536 1.1× 175 0.4× 171 0.5× 35 1.5k
Dell Paielli 1.2k 1.0× 1.2k 1.2× 745 1.6× 229 0.6× 350 0.9× 13 1.8k
Patrice Yeh 751 0.6× 1.1k 1.1× 373 0.8× 76 0.2× 176 0.5× 25 1.6k
Ken N. Wills 956 0.8× 1.2k 1.2× 567 1.2× 75 0.2× 306 0.8× 28 1.8k
Evelyn M. Karson 821 0.7× 861 0.9× 422 0.9× 108 0.3× 97 0.3× 25 1.5k
Phillip B. Maples 852 0.7× 1.1k 1.1× 1.2k 2.5× 148 0.4× 329 0.9× 37 2.1k

All Works

Loading papers...

Rankless by CCL
2026